Andreas Ziegler Selected Research

HLA-B*27:09 antigen

8/2008	Molecular determinants of major histocompatibility complex class I complex stability: shaping antigenic features through short and long range electrostatic interactions.
2/2008	HLA-B27 subtypes differentially associated with disease exhibit conformational differences in solution.
3/2005	Thermodynamic and structural equivalence of two HLA-B27 subtypes complexed with a self-peptide.
1/2005	Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes.
7/2004	Differential peptide dynamics is linked to major histocompatibility complex polymorphism.
1/2004	Dual, HLA-B27 subtype-dependent conformation of a self-peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Ziegler Research Topics

Disease

16	Ankylosing Spondylitis 01/2020 - 02/2003
8	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2022 - 01/2019
8	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2004
8	Neoplasms (Cancer) 10/2012 - 01/2002
7	Spondylarthropathies 10/2013 - 12/2002
6	Intracranial Aneurysm (Cerebral Aneurysm) 01/2008 - 01/2003
5	Infections 08/2019 - 04/2005
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2015 - 08/2008
5	Melanoma (Melanoma, Malignant) 01/2009 - 12/2002
4	Myocardial Infarction 01/2021 - 11/2008
4	Hypersensitivity (Allergy) 07/2019 - 02/2003
3	Hypertension (High Blood Pressure) 02/2020 - 10/2006
3	Wounds and Injuries (Trauma) 11/2019 - 05/2008
3	Rheumatic Diseases (Rheumatism) 01/2019 - 04/2010
3	Birth Weight (Birth Weights) 01/2018 - 08/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2017 - 10/2014
3	Stroke (Strokes) 10/2017 - 11/2008
3	Malaria 09/2012 - 03/2007
3	Multiple Sclerosis 03/2012 - 03/2002
3	Inflammation (Inflammations) 05/2011 - 06/2004
2	Brain Diseases (Brain Disorder) 01/2022 - 01/2020
2	Glycogen Storage Disease Type II (Pompe's Disease) 12/2021 - 04/2021
2	Atrial Fibrillation 02/2020 - 02/2018
2	Epilepsy (Aura) 01/2020 - 01/2019
2	Hypoxia (Hypoxemia) 01/2017 - 09/2005
2	Type 2 Diabetes Mellitus (MODY) 10/2015 - 01/2012
2	Fibrosis (Cirrhosis) 01/2015 - 10/2010
2	Erythema 01/2015 - 04/2012
2	Agoraphobia 10/2014 - 02/2013
2	Panic Disorder (Panic Attack) 10/2014 - 02/2013
2	Fecal Incontinence 11/2013 - 07/2010
2	Colorectal Neoplasms (Colorectal Cancer) 07/2012 - 10/2011
2	Breast Neoplasms (Breast Cancer) 04/2012 - 10/2010
2	Aneuploidy (Aneuploid) 01/2012 - 10/2011
2	Lung Diseases (Lung Disease) 01/2009 - 04/2005
2	Aneurysm (Aneurysms) 01/2008 - 01/2003
2	Tuberculosis (Tuberculoses) 06/2007 - 10/2005
2	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2004 - 01/2002
2	Allergic Contact Dermatitis 12/2003 - 02/2003
1	Spinal Muscular Atrophies of Childhood (Werdnig Hoffman Disease) 01/2021
1	Diverticulum 11/2020
1	Hereditary Spastic Paraplegia 10/2020
1	Polymicrogyria 10/2020
1	Heart Failure 02/2020
1	Autonomic Nervous System Diseases (Dysautonomia) 01/2020
1	Neuralgia (Stump Neuralgia) 01/2020
1	Paresis (Hemiparesis) 01/2020
1	Isaacs Syndrome (Neuromyotonia) 01/2020

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 10/2020 - 06/2002
11	HLA-B27 Antigen (HLA B27 Antigen)IBA 07/2013 - 06/2002
10	Peptides (Polypeptides)IBA 01/2020 - 01/2004
7	Biomarkers (Surrogate Marker)IBA 10/2021 - 06/2007
6	HLA-B Antigens (HLA-B)IBA 01/2019 - 12/2005
6	HLA-B*27:05 antigenIBA 08/2008 - 01/2004
6	HLA-B*27:09 antigenIBA 08/2008 - 01/2004
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019 - 01/2004
4	AntigensIBA 07/2013 - 03/2002
4	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 04/2002
4	CytokinesIBA 12/2008 - 01/2002
3	nusinersenIBA 01/2022 - 01/2020
3	CholesterolIBA 01/2019 - 11/2008
3	Insulin (Novolin)FDA Link 12/2018 - 08/2010
3	LDL CholesterolIBA 08/2010 - 08/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2008 - 01/2002
2	ZolgensmaIBA 01/2022 - 08/2019
2	EnzymesIBA 01/2022 - 06/2006
2	CalciumIBA 11/2020 - 09/2012
2	IronIBA 10/2020 - 01/2018
2	Amino Acids FDA Link 01/2020 - 08/2008
2	MagnesiumIBA 08/2019 - 07/2019
2	AlloysIBA 08/2019 - 07/2019
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 08/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 08/2014
2	Interleukin-18 (Interleukin 18)IBA 10/2015 - 12/2008
2	Surface-Active Agents (Surfactants)IBA 03/2015 - 11/2011
2	LipidsIBA 01/2015 - 08/2012
2	HDL CholesterolIBA 08/2012 - 08/2010
2	Codon (Codons)IBA 04/2012 - 10/2010
2	AdiponectinIBA 01/2012 - 08/2010
2	AcidsIBA 04/2010 - 10/2006
2	Immunoglobulin FragmentsIBA 01/2009 - 01/2005
2	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2009 - 04/2005
2	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2008 - 01/2007
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2007 - 06/2004
2	InterleukinsIBA 02/2003 - 01/2002
1	Inosine TriphosphataseIBA 01/2022
1	Inosine Triphosphate (ITP)IBA 01/2022
1	PyrophosphatasesIBA 01/2022
1	purineIBA 01/2022
1	TroponinIBA 01/2021
1	Adaptor Protein Complex 4IBA 10/2020
1	Antisense OligonucleotidesIBA 01/2020
1	AntibodiesIBA 01/2020

Therapy/Procedure

18	Therapeutics 01/2022 - 01/2002
5	Radiotherapy 08/2017 - 05/2008
2	Home Infusion Therapy 12/2021 - 04/2021
2	Lasers (Laser) 03/2007 - 09/2005
1	Palliative Care (Palliative Therapy) 01/2021
1	Ambulatory Care (Outpatient Care) 02/2020
1	Operative Surgical Procedures 11/2019